Concepedia

Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists

Alan D. Adams, Winston Yuen, Zao Hu, Conrad Santini, A. Brian Jones, Karen L. MacNaul, Joel P. Berger, Thomas W. Doebber, David E. Moller

Bioorganic & Medicinal Chemistry Letters · 2003 · 37 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi Cheng, William H. Prusoff · Biochemical Pharmacology · 1973 · 12.9K citations

, , +14

Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors

H. Eric Xu, Millard H. Lambert, Valerie G. Montana et al. · Molecular Cell · 1999 · 1.2K citations · Full text

, , +12

On the attribution and additivity of binding energies

William P. Jencks · Proceedings of the National Academy of Sciences · 1981 · 921 citations · Full text

, , +17

Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects

Joel P. Berger, Mark D. Leibowitz, Thomas W. Doebber et al. · Journal of Biological Chemistry · 1999 · 412 citations · Full text

, , +17

Hepatic Failure in a Patient Taking Rosiglitazone

Lisa Forman, David A. Simmons, Robert H. Diamond · Annals of Internal Medicine · 2000 · 213 citations

, , +17